Pandemic influenza vaccine H5N1 AstraZeneca (previously Pandemic influenza vaccine H5N1 Medimmune) Den europeiske union - engelsk - EMA (European Medicines Agency)

pandemic influenza vaccine h5n1 astrazeneca (previously pandemic influenza vaccine h5n1 medimmune)

astrazeneca ab - reassortant influenza virus (live attenuated) of the following strain: a/vietnam/1203/2004 (h5n1) strain - influenza, human - vaccines - prophylaxis of influenza in an officially declared pandemic situation in children and adolescents from 12 months to less than 18 years of age.pandemic influenza vaccine h5n1 astrazeneca should be used in accordance with official guidance

Tremelimumab AstraZeneca Den europeiske union - engelsk - EMA (European Medicines Agency)

tremelimumab astrazeneca

astrazeneca ab - tremelimumab - carcinoma, non-small-cell lung - antineoplastic agents - tremelimumab astrazeneca in combination with durvalumab and platinum-based chemotherapy is indicated for the first-line treatment of adults with metastatic non-small cell lung cancer (nsclc) with no sensitising egfr mutations or alk positive mutations.

Pandemic influenza vaccine H5N1 AstraZeneca (previously Pandemic influenza vaccine H5N1 Medimmune) Den europeiske union - fransk - EMA (European Medicines Agency)

pandemic influenza vaccine h5n1 astrazeneca (previously pandemic influenza vaccine h5n1 medimmune)

astrazeneca ab - virus grippal réassorti (vivant atténué) de la souche suivante: a / vietnam / 1203/2004 (h5n1) - grippe humaine - vaccins - prophylaxie de la grippe dans une situation de pandémie officiellement déclarée chez les enfants et les adolescents de 12 mois à moins de 18 ans. vaccin contre la grippe pandémique h5n1 astrazeneca doit être utilisé selon les recommandations officielles.

NASOCORT AQUA 64 MCGDOSE Israel - engelsk - Ministry of Health

nasocort aqua 64 mcgdose

astra zeneca (israel) ltd - budesonide micronized - nasal spray - budesonide micronized 1.28 mg/ml - budesonide - budesonide - seasonal and perennial allergic rhinitis, and vasomotor rhinitis. preventively against nasal polyps after polypectomy. symptomatic treatment in nasal polyposis.

Nexium 40 mg zarnās šķīstošās tabletes Latvia - latvisk - Zāļu valsts aģentūra

nexium 40 mg zarnās šķīstošās tabletes

astrazeneca ab, sweden - esomeprazols - zarnās šķīstošā tablete - 40 mg

Nexium 20 mg zarnās šķīstošās tabletes Latvia - latvisk - Zāļu valsts aģentūra

nexium 20 mg zarnās šķīstošās tabletes

astrazeneca ab, sweden - esomeprazols - zarnās šķīstošā tablete - 20 mg

Nexium 40 mg pulveris injekciju vai infūziju šķīduma pagatavošanai Latvia - latvisk - Zāļu valsts aģentūra

nexium 40 mg pulveris injekciju vai infūziju šķīduma pagatavošanai

astrazeneca ab, sweden - esomeprazols - pulveris injekciju/infūziju šķīduma pagatavošanai - 40 mg

Pulmicort 0,5 mg/ml suspensija izsmidzināšanai Latvia - latvisk - Zāļu valsts aģentūra

pulmicort 0,5 mg/ml suspensija izsmidzināšanai

astrazeneca ab, sweden - budezonīds - suspensija izsmidzināšanai - 0,5 mg/ml

Pulmicort 0,5 mg/ml suspensija izsmidzināšanai Latvia - latvisk - Zāļu valsts aģentūra

pulmicort 0,5 mg/ml suspensija izsmidzināšanai

astrazeneca ab, sweden - budezonīds - suspensija izsmidzināšanai - 0,5 mg/ml

NEXIUM TABLETS 20 MG Israel - engelsk - Ministry of Health

nexium tablets 20 mg

astrazeneca (israel) ltd - esomeprazole - tablets - esomeprazole 20 mg - esomeprazole - esomeprazole - nexium tablets are indicated in adults for:gastroesophageal reflux disease (gerd)- treatment of erosive reflux esophagitis- long-term management of patients with healed esophagitis to prevent relapse- symptomatic treatment of gastroesophageal reflux disease (gerd)in combination with an appropriate antibacterial therapeutic regimen for the eradication of helicobacter pylori and:- healing of helicobacter pylori associated duodenal ulcer and- prevention of relapse of peptic ulcers in patients with helicobacter pylori associated ulcers.patients requiring nsaid therapy- healing of gastric ulcers associated with nsaid therapy. - prevention of gastric and duodenal ulcers associated with nsaid therapy in patients at risk.prolonged treatment after i.v. induced prevention of rebleeding of peptic ulcers.nexium 20 mg tablets are indicated in adolescents from the age of 12 years forgastroesophageal reflux disease (gerd)- treatment of erosive reflux esophagitis- long-term management of patients with healed esophagi